Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Neonicotinoid review delayed until autumn
bee
A recent study suggested exposure to neonicotinoids could impair bumblebees’ ability to learn, with negative consequences for ‘buzz pollination’.
Extra time needed to consider ‘large amount of information’

A review of three neonicotinoid pesticides, which are partially banned in the EU, has been delayed until later this year.

Restrictions were placed on the use of clothianidin, imidacloprid and thiametoxam in December 2013 owing to concerns about their impact on bees.

A review by the European Food Safety Authority (EFSA) was due to be finalised this month but will now be delayed until autumn 2017 “to ensure adequate time to consider the very large amount of information received during the call for data”.

An EFSA spokesperson said: “When it imposed controls on neonicotinoids in 2013 the European Commission announced that work on the full re-evaluation of the three neonicotinoids would begin within two years. In 2015, EFSA therefore issued a call for data and commissioned a literature search to gather evidence on which to base these new assessments.

“The information from the call for data included peer-reviewed articles published in journals, study reports, monitoring data, reviews, notes and datasets.”

EFSA is reviewing the risks to bees, looking at seed treatments and granules and taking new data into consideration. The food safety watchdog confirmed the three substances were a threat to bees when used as foliar sprays in 2015.

Much research has been published on the effects of neonicotinoids in recent years - last year alone imidacloprid and thiametoxam were found to reduce the lifespan and number of living sperm produced by male honey bees. Another 18-year study indicated a link between large scale bee declines and exposure to oilseed rape crops that had been treated with neonicotinoids.

A freedom of information request also revealed that studies commissioned by Bayer and Syngenta suggested their own pesticides could cause serious harm to honey bees at high concentrations.

Just last month, a study by the University of Stirling suggested exposure to neonicotinoids could impair bumblebees’ ability to learn, with negative consequences for a type of pollination, known as ‘buzz pollination’ that requires bees to produce vibrations.

Friends of the Earth is calling for a complete ban on the use of neonicotinoids, but National Farmers’ Union vice president Guy Smith is quoted by Farmers Weekly as saying a ban would be “unjustified” under current scientific evidence.

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.